The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE

Nishant P. Shah; Qiuqing Wang; Katherine E. Wolski; Leslie Cho; Ellen McErlean; Giacomo Ruotolo; Govinda Weerakkody; Jeffrey S. Riesmeyer; Stephen J. Nicholls; A. Michael Lincoff; Steven E. Nissen; Venu Menon

doi:10.2337/dc19-1117

The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE

Nishant P. Shah
, Qiuqing Wang
, Katherine E. Wolski
, Leslie Cho
, Ellen McErlean
, Giacomo Ruotolo
, Govinda Weerakkody
, Jeffrey S. Riesmeyer
, Stephen J. Nicholls
, A. Michael Lincoff
, Steven E. Nissen
, Venu Menon

Medicine Monash Health

Research output: Contribution to journal › Letter › Other › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	e22-e24
Number of pages	3
Journal	Diabetes Care
Volume	43
Issue number	2
DOIs	https://doi.org/10.2337/dc19-1117
Publication status	Published - 1 Feb 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2337/dc19-1117

Cite this

Shah, N. P., Wang, Q., Wolski, K. E., Cho, L., McErlean, E., Ruotolo, G., Weerakkody, G., Riesmeyer, J. S., Nicholls, S. J., Lincoff, A. M., Nissen, S. E., & Menon, V. (2020). The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE. Diabetes Care, 43(2), e22-e24. https://doi.org/10.2337/dc19-1117

@article{069a69f7f18a4827abe32c229e740f43,

title = "The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE",

author = "Shah, \{Nishant P.\} and Qiuqing Wang and Wolski, \{Katherine E.\} and Leslie Cho and Ellen McErlean and Giacomo Ruotolo and Govinda Weerakkody and Riesmeyer, \{Jeffrey S.\} and Nicholls, \{Stephen J.\} and Lincoff, \{A. Michael\} and Nissen, \{Steven E.\} and Venu Menon",

year = "2020",

month = feb,

day = "1",

doi = "10.2337/dc19-1117",

language = "English",

volume = "43",

pages = "e22--e24",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "2",

}

Shah, NP, Wang, Q, Wolski, KE, Cho, L, McErlean, E, Ruotolo, G, Weerakkody, G, Riesmeyer, JS, Nicholls, SJ, Lincoff, AM, Nissen, SE & Menon, V 2020, 'The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE', Diabetes Care, vol. 43, no. 2, pp. e22-e24. https://doi.org/10.2337/dc19-1117

The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE. / Shah, Nishant P.; Wang, Qiuqing; Wolski, Katherine E. et al.
In: Diabetes Care, Vol. 43, No. 2, 01.02.2020, p. e22-e24.

Research output: Contribution to journal › Letter › Other › peer-review

TY - JOUR

T1 - The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy

T2 - Post Hoc Analysis of ACCELERATE

AU - Shah, Nishant P.

AU - Wang, Qiuqing

AU - Wolski, Katherine E.

AU - Cho, Leslie

AU - McErlean, Ellen

AU - Ruotolo, Giacomo

AU - Weerakkody, Govinda

AU - Riesmeyer, Jeffrey S.

AU - Nicholls, Stephen J.

AU - Lincoff, A. Michael

AU - Nissen, Steven E.

AU - Menon, Venu

PY - 2020/2/1

Y1 - 2020/2/1

UR - https://www.scopus.com/pages/publications/85078393297

U2 - 10.2337/dc19-1117

DO - 10.2337/dc19-1117

M3 - Letter

C2 - 31806654

AN - SCOPUS:85078393297

SN - 0149-5992

VL - 43

SP - e22-e24

JO - Diabetes Care

JF - Diabetes Care

IS - 2

ER -

The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE

UN SDGs

Access to Document

Other files and links

Cite this